Aktie SQURPHARMA SQUARE PHARMACEUTICALS PLC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Square Pharmaceuticals PLC.

Aktien

SQURPHARMA

BD0473SQPH00

SQURPHARMA

Schlusskurs Dhaka S.E.
Andere Börsenplätze
 00:00:00 09.05.2024 		% 5 Tage % 1. Jan.
212,2 BDT -0,38 % Intraday Chart für Square Pharmaceuticals PLC. +0,62 % +0,90 %
30.04. Square Pharmaceuticals PLC. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. März 2024 CI
01.02. Square Pharmaceuticals PLC. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Square Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Square Pharmaceuticals PLC. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Square Pharmaceuticals PLC. Reports Earnings Results for the First Quarter Ended September 30, 2023
Square Pharmaceuticals PLC. Recommends Cash Dividend for the Year Ended June 30, 2023
Square Pharmaceuticals PLC Announces Contract Manufacturing Agreement with M/S Aristopharma Ltd
Square Pharmaceuticals Limited has Changed its Name to Square Pharmaceuticals PLC
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Square Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021
Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021
Square Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2020
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020
Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir-COO
Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO
Square Pharmaceuticals : Industries at Pabna BSCIC continue production of medicines, essentials
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SQURPHARMA Aktie
  4. Nachrichten Square Pharmaceuticals PLC.
  5. Andere Sprachen